Key Takeaways
- • Veritas Capital to acquire Bodycote plc at 940 pence per share, comprising 932.8 pence in cash plus a 7.2 pence FY26 interim dividend, representing a 37.5% premium to the three-month undisturbed VWAP of 683.4 pence as of 21 May 2026.
- • Total transaction valued at approximately £1.64 billion in cash consideration on a fully diluted equity basis, with enterprise value of £1.84 billion, following a competitive process that included Apollo's unsolicited approach (later withdrawn) and competing bids from CVC Capital Partners.
- • Bodycote board unanimously recommends the deal, backed by advisers Barclays, Goldman Sachs, and Gleacher Shacklock, with director irrevocables covering 252,480 shares; transaction structured as a Part 26 court-sanctioned scheme with expected completion in Q1 2027 subject to regulatory approvals.
- • Veritas acquires the world's largest heat-treatment and specialist thermal-processing network comprising approximately 130 facilities across 22 countries, adding to its aerospace-and-defence-adjacent industrial portfolio.
- • Veritas Capital manages approximately $54 billion in assets as of 30 June 2026, positioning this acquisition as a significant deployment within its alternative investment platform.
Summary
Veritas Capital Fund Management has agreed to acquire Bodycote plc, a London-listed thermal-processing and heat-treatment specialist, at 940 pence per share in an all-cash transaction announced on 2 September 2026. The offer comprises 932.8 pence in cash plus the company's FY26 interim dividend of 7.2 pence per share retained by shareholders. The transaction implies an equity value of £1.64 billion and an enterprise value of £1.84 billion on a fully diluted basis.
The acquisition represents a significant premium to Bodycote's pre-offer valuation. The 940 pence offer price delivers a 37.5% premium to the three-month undisturbed volume-weighted average price of 683.4 pence as of 21 May 2026, and a 25.3% premium to the closing price of 750.2 pence on 4 August 2026, the last business day before the offer period commenced. The deal emerged from a competitive process initiated when Apollo made an unsolicited approach on 22 May 2026, which was subsequently withdrawn. Bodycote then engaged in parallel negotiations with Veritas Capital and CVC Capital Partners. CVC's improved proposal reached 915 pence including the dividend, while Veritas initially matched that level at 914 pence before raising its bid to 940 pence on 31 August.
The Bodycote board, advised by Barclays, Goldman Sachs, and Gleacher Shacklock as Rule 3 adviser, intends to recommend the transaction unanimously. Director irrevocables cover approximately 252,480 shares, representing 0.15% of the company's issued capital of 170,187,993 ordinary shares. The transaction will proceed as a court-sanctioned scheme under Part 26 of the Companies Act, with the Scheme Document expected within 28 days and an expected Effective Date in Q1 2027, subject to shareholder approval, Court sanction, and competition and regulatory clearances.
The acquisition marks Veritas Capital's continued expansion within aerospace-and-defence-adjacent industrial assets. Bodycote operates the world's largest heat-treatment and specialist thermal-processing network, comprising approximately 130 facilities across 22 countries, serving aerospace, defence, automotive, and industrial applications. Veritas, with $54 billion in assets under management as of 30 June 2026, is taking the company private and adding it to its industrial portfolio.
The acquisition represents a significant premium to Bodycote's pre-offer valuation. The 940 pence offer price delivers a 37.5% premium to the three-month undisturbed volume-weighted average price of 683.4 pence as of 21 May 2026, and a 25.3% premium to the closing price of 750.2 pence on 4 August 2026, the last business day before the offer period commenced. The deal emerged from a competitive process initiated when Apollo made an unsolicited approach on 22 May 2026, which was subsequently withdrawn. Bodycote then engaged in parallel negotiations with Veritas Capital and CVC Capital Partners. CVC's improved proposal reached 915 pence including the dividend, while Veritas initially matched that level at 914 pence before raising its bid to 940 pence on 31 August.
The Bodycote board, advised by Barclays, Goldman Sachs, and Gleacher Shacklock as Rule 3 adviser, intends to recommend the transaction unanimously. Director irrevocables cover approximately 252,480 shares, representing 0.15% of the company's issued capital of 170,187,993 ordinary shares. The transaction will proceed as a court-sanctioned scheme under Part 26 of the Companies Act, with the Scheme Document expected within 28 days and an expected Effective Date in Q1 2027, subject to shareholder approval, Court sanction, and competition and regulatory clearances.
The acquisition marks Veritas Capital's continued expansion within aerospace-and-defence-adjacent industrial assets. Bodycote operates the world's largest heat-treatment and specialist thermal-processing network, comprising approximately 130 facilities across 22 countries, serving aerospace, defence, automotive, and industrial applications. Veritas, with $54 billion in assets under management as of 30 June 2026, is taking the company private and adding it to its industrial portfolio.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.